| 1 |
34903667 | Components of the phosphatidylserine endoplasmic reticulum to plasma membrane transport mechanism as targets for KRAS inhibition in pancreatic cancer. | 2021 Dec 21 |
2 |
| 2 |
30880098 | Prevalence of baseline NS3 resistance-associated substitutions (RASs) on treatment with protease inhibitors in patients infected with HCV genotype 1. | 2019 Nov |
1 |
| 3 |
28228479 | Unraveling the structural basis of grazoprevir potency against clinically relevant substitutions in hepatitis C virus NS3/4A protease from genotype 1a. | 2017 Apr 14 |
1 |
| 4 |
28270091 | Implications of hepatitis C virus subtype 1a migration patterns for virus genetic sequencing policies in Italy. | 2017 Mar 7 |
2 |
| 5 |
28569206 | Virology analysis in HCV genotype 1-infected patients treated with the combination of simeprevir and TMC647055/ritonavir, with and without ribavirin, and JNJ-56914845. | 2017 May 31 |
1 |
| 6 |
28877086 | Short article: Retreatment of chronic hepatitis C virus infection after unsuccessful therapy with all-oral direct-acting antiviral regimens: a real-life experience. | 2017 Nov |
1 |
| 7 |
28011961 | Genotypic analysis of HCV 1a by sequencing of the NS3 proteasic region in simeprevir therapy candidates. | 2016 Dec 1 |
4 |
| 8 |
25389307 | Global origin and transmission of hepatitis C virus nonstructural protein 3 Q80K polymorphism. | 2015 Apr 15 |
1 |
| 9 |
25529083 | How to optimize current therapy in hepatitis C virus genotype 1 patients. Predictors of response to interferon-based therapy with second wave direct acting antivirals. | 2015 Jan |
1 |
| 10 |
25959702 | Diversity of 1,213 hepatitis C virus NS3 protease sequences from a clinical virology laboratory database in Marseille university hospitals, southeastern France. | 2015 Nov |
1 |
| 11 |
26135875 | Development and Validation of Two Screening Assays for the Hepatitis C Virus NS3 Q80K Polymorphism Associated with Reduced Response to Combination Treatment Regimens Containing Simeprevir. | 2015 Sep |
2 |
| 12 |
26213689 | Two Distinct Hepatitis C Virus Genotype 1a Clades Have Different Geographical Distribution and Association With Natural Resistance to NS3 Protease Inhibitors. | 2015 Apr |
1 |
| 13 |
26232533 | Detection of the NS3 Q80K polymorphism by Sanger and deep sequencing in hepatitis C virus genotype 1a strains in the UK. | 2015 Nov |
1 |
| 14 |
26248125 | Resistance to direct-acting antiviral agents: clinical utility and significance. | 2015 Sep |
1 |
| 15 |
26249823 | Predominance of hepatitis C virus Q80K among NS3 baseline-resistance-associated amino acid variants in direct-antiviral-agent-naïve patients with chronic hepatitis: single-centre experience. | 2015 Nov |
4 |
| 16 |
26392483 | In Vitro Activity of Simeprevir against Hepatitis C Virus Genotype 1 Clinical Isolates and Its Correlation with NS3 Sequence and Site-Directed Mutants. | 2015 Dec |
6 |
| 17 |
25002352 | Antiviral treatment of hepatitis C. | 2014 Jul 7 |
1 |
| 18 |
25397486 | Appearance of NS3 Q80K mutation in HCV genotype 1a mono- or HIV/HCV co-infected patients in a Berlin laboratory. | 2014 |
1 |
| 19 |
22127068 | Molecular modeling study on the resistance mechanism of HCV NS3/4A serine protease mutants R155K, A156V and D168A to TMC435. | 2012 Jan |
6 |
| 20 |
18678486 | Structure-activity relationship study on a novel series of cyclopentane-containing macrocyclic inhibitors of the hepatitis C virus NS3/4A protease leading to the discovery of TMC435350. | 2008 Sep 1 |
1 |